Our team is continually researching new eyelid-based biomarkers to detect impairment and keep road users safe
They say your strengths can become your weaknesses, but in my case, perhaps my weaknesses have become my strengths
Journal reference: Jastreboff AM
A GLP-1 Vision Loss Lawsuit is a legal claim filed by individuals who have experienced sudden or permanent vision loss, such as non-arteritic anterior ischemic optic neuropathy (NAION), after using GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound
McGraw-Hill / Lange rxlist.com (Januvia ) Keywords Saxagliptin Trade Name: Onglyza Mechanism of Action: a DPP-4 inhibitor, similar to Sitagliptin Pharmacokinetics: mixed renal & hepatic clearance dosage should be reduced in patients with moderate to severe renal impairment References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)